Gavin Mac Beath T Scan Therapeutics, Inc. (TCRX) insider trading activity

TCRX Quotes by TradingView

Gavin Mac Beath is Chief Executive Officer of TScan Therapeutics, Inc.. Currently has a direct ownership of 49,767 shares of TCRX, which is worth approximately $153,282. The most recent transaction as insider was on Sep 21, 2021, when has been sold 57 shares (Voting Common Stock) at a price of $6.19 per share, resulting in proceeds of $353. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 49.8K
0% 3M change
0% 12M change
Total Value Held $153,282

Gavin MacBeath Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 21 2021
BUY
Open market or private purchase
$353 $6.19 p/Share
57 Added 0.11%
49,767 Voting Common Stock
Sep 20 2021
BUY
Open market or private purchase
$30,745 $6.22 p/Share
4,943 Added 9.04%
49,710 Voting Common Stock
GM

Gavin Mac Beath

Chief Executive Officer
Waltham, MA

Track Institutional and Insider Activities on TCRX

Follow TScan Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TCRX shares.

Notify only if

Insider Trading

Get notified when an T Scan Therapeutics, Inc. insider buys or sells TCRX shares.

Notify only if

News

Receive news related to TScan Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TCRX